300 related articles for article (PubMed ID: 19418409)
1. Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology.
Heringlake S; Schütte A; Flemming P; Schmiegel W; Manns MP; Tillmann HL
Z Gastroenterol; 2009 May; 47(5):417-23. PubMed ID: 19418409
[TBL] [Abstract][Full Text] [Related]
2. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.
Caldwell SH; Oelsner DH; Iezzoni JC; Hespenheide EE; Battle EH; Driscoll CJ
Hepatology; 1999 Mar; 29(3):664-9. PubMed ID: 10051466
[TBL] [Abstract][Full Text] [Related]
3. The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients.
Mathiesen UL; Franzén LE; Frydén A; Foberg U; Bodemar G
Scand J Gastroenterol; 1999 Jan; 34(1):85-91. PubMed ID: 10048738
[TBL] [Abstract][Full Text] [Related]
4. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
5. Re-analysis of clinical features of 89 patients with autoimmune hepatitis using the revised scoring system proposed by the International Autoimmune Hepatitis Group.
Omagari K; Masuda J; Kato Y; Nakata K; Kanematsu T; Kusumoto Y; Mori I; Furukawa R; Tanioka H; Tajima H; Koga M; Yano M; Kohno S
Intern Med; 2000 Dec; 39(12):1008-12. PubMed ID: 11197782
[TBL] [Abstract][Full Text] [Related]
6. [Autoimmune hepatitis and overlap syndrome: diagnosis].
Berg PA; Klein R
Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
Bonder A; Retana A; Winston DM; Leung J; Kaplan MM
Clin Gastroenterol Hepatol; 2011 Jul; 9(7):609-12. PubMed ID: 21440668
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of GB virus-C/hepatitis G virus infection in patients with cryptogenic chronic liver disease and in patients with primary biliary cirrhosis or Wilson's disease.
Tagger A; Ribero ML; Larghi A; Donato F; Zuin M; Chiesa R; Benetti G; Ramella G; Borzio M; Podda M
Am J Gastroenterol; 1999 Feb; 94(2):484-8. PubMed ID: 10022651
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of non-organ-specific autoantibodies in a rural community from northeastern Brazil: a population-based study.
Cunha LM; Bittencourt PL; Abrantes-Lemos CP; Moreira A; Almeida D; Parana R; Andrade Z
Hum Immunol; 2012 Jan; 73(1):70-4. PubMed ID: 22027387
[TBL] [Abstract][Full Text] [Related]
10. Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis?
Kaymakoglu S; Cakaloglu Y; Demir K; Türkoglu S; Badur S; Gürel S; Beşişik F; Cevikbaş U; Okten A
J Hepatol; 1998 Jan; 28(1):78-83. PubMed ID: 9537867
[TBL] [Abstract][Full Text] [Related]
11. Cryptogenic cirrhosis: a vanishing entity.
Desai HG
J Assoc Physicians India; 2009 Nov; 57():751-4, 759. PubMed ID: 20329442
[TBL] [Abstract][Full Text] [Related]
12. Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients.
Qiu D; Wang Q; Wang H; Xie Q; Zang G; Jiang H; Tu C; Guo J; Zhang S; Wang J; Lu Y; Han Y; Shen L; Chen X; Hu X; Wang X; Chen C; Fu Q; Ma X
J Hepatol; 2011 Feb; 54(2):340-7. PubMed ID: 21056494
[TBL] [Abstract][Full Text] [Related]
13. Are bile duct lesions of primary biliary cirrhosis distinguishable from those of autoimmune hepatitis and chronic viral hepatitis? Interobserver histological agreement on trimmed bile ducts.
Zen Y; Harada K; Sasaki M; Tsuneyama K; Matsui K; Haratake J; Sakisaka S; Maeyama S; Yamamoto K; Nakano M; Shimamatsu K; Kage M; Kurose N; Uchiyama A; Kaizaki Y; Toda G; Nakanuma Y
J Gastroenterol; 2005 Feb; 40(2):164-70. PubMed ID: 15770400
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of overlap syndromes.
Bunchorntavakul C; Reddy KR
Clin Liver Dis; 2015 Feb; 19(1):81-97. PubMed ID: 25454298
[TBL] [Abstract][Full Text] [Related]
15. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
Manns MP; Obermayer-Straub P
Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
[TBL] [Abstract][Full Text] [Related]
16. [Presence of SLA/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome)].
Kanzler S; Bozkurt S; Herkel J; Galle PR; Dienes HP; Lohse AW
Dtsch Med Wochenschr; 2001 Apr; 126(16):450-6. PubMed ID: 11360449
[TBL] [Abstract][Full Text] [Related]
17. Is cryptogenic cirrhosis different from NASH cirrhosis?
Thuluvath PJ; Kantsevoy S; Thuluvath AJ; Savva Y
J Hepatol; 2018 Mar; 68(3):519-525. PubMed ID: 29162389
[TBL] [Abstract][Full Text] [Related]
18. Non-organ-specific autoantibodies in Indian patients with chronic liver disease.
Daschakraborty S; Aggarwal A; Aggarwal R
Indian J Gastroenterol; 2012 Sep; 31(5):237-42. PubMed ID: 22941677
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune hepatitis in a Jamaican cohort spanning 40 years.
Roye-Green K; Willis R; Mc Morris N; Dawson J; Whittle D; Barton E; Smikle M
Hum Antibodies; 2013; 22(3-4):87-93. PubMed ID: 24961867
[TBL] [Abstract][Full Text] [Related]
20. [Clinical features of chronic hepatitis].
López EM; de la Torre M
Rev Invest Clin; 1990 Jul; 42 Suppl():9-16. PubMed ID: 19256126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
